Results 111 to 120 of about 12,683 (169)

Mevalonate kinase deficiency: an updated clinical overview and revision of the SHARE recommendations. [PDF]

Front Immunol
Lengvári L, Takács K, Lengyel A, Pálinkás A, Wouters CH, Koné-Paut I, Kuemmerle-Deschner J, Jeyaratnam J, Anton J, Lachmann HJ, Gattorno M, Hofer M, Toplak N, Weiser P, Kallinich T, Ozen S, Hentgen V, Uziel Y, Horváth Z, Szabados M, Brogan P, Constantin T, Frenkel J.   +22 more
europepmc   +1 more source

Structural Characterization and Functional Analysis of Mevalonate Kinase from Tribolium castaneum (Red Flour Beetle). [PDF]

Int J Mol Sci
Zheng H, Yang Y, Hu Y, Shi J, Li Q, Wang Y, Xia Q, Guo P.   +7 more
europepmc   +1 more source

The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin-Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin-1 Receptor Antagonist. [PDF]

Arthritis Rheumatol, 2022
Romano M, Arici ZS, Piskin D, Alehashemi S, Aletaha D, Barron K, Benseler S, Berard RA, Broderick L, Dedeoglu F, Diebold M, Durrant K, Ferguson P, Foell D, Hausmann JS, Jones OY, Kastner D, Lachmann HJ, Laxer RM, Rivera D, Ruperto N, Simon A, Twilt M, Frenkel J, Hoffman HM, de Jesus AA, Kuemmerle-Deschner JB, Ozen S, Gattorno M, Goldbach-Mansky R, Demirkaya E.   +30 more
europepmc   +1 more source

Mevalonate kinase-deficient THP-1 cells show a disease-characteristic pro-inflammatory phenotype. [PDF]

Front Immunol
Politiek FA, Turkenburg M, Ofman R, Waterham HR.   +3 more
europepmc   +1 more source

Tocilizumab for treating mevalonate kinase deficiency and TNF receptor-associated periodic syndrome: a case series and literature review. [PDF]

Pediatr Rheumatol Online J
Li Y, Lu M.
europepmc   +1 more source

Immunodeficiency-Like Phenotype, Recurrent Pulmonary Manifestations, and Persistent Polyarthritis: Mevalonate Kinase Deficiency Successfully Treated With Adalimumab. [PDF]

Arch Rheumatol, 2020
Çakan M, Aktay Ayaz N, Erol Çipe F, Gül Karadağ Ş.   +3 more
europepmc   +1 more source

Spectrum of clinical features and genetic variants in mevalonate kinase (MVK) gene of South Indian families suffering from Hyperimmunoglobulin D Syndrome. [PDF]

PLoS One, 2020
Govindaraj GM, Jain A, Peethambaran G, Bhoyar RC, Vellarikkal SK, Ganapati A, Sandhya P, Edavazhippurath A, Dhanasooraj D, Puthenpurayil JM, Chakkiyar K, Mishra A, Batra A, Punnen A, Kumar S, Sivasubbu S, Scaria V.   +16 more
europepmc   +1 more source

Effects of mevalonate kinase interference on cell differentiation, apoptosis, prenylation and geranylgeranylation of human keratinocytes are attenuated by farnesyl pyrophosphate or geranylgeranyl pyrophosphate. [PDF]

Exp Ther Med, 2020
Li M, Min W, Wang J, Wang L, Li Y, Zhou N, Yang Z, Qian Q.   +7 more
europepmc   +1 more source

Correction: Directed evolution of mevalonate kinase in Escherichia coli by random mutagenesis for improved lycopene. [PDF]

RSC Adv, 2019
Chen H, Liu C, Li M, Zhang H, Xian M, Liu H.   +5 more
europepmc   +1 more source

HSCT in mevalonate kinase deficiency

Pediatric Rheumatology, 2013
Wolska-Kuśnierz, Beata, Kałwak, Krzysztof, Bernatowska, Ewa, Rowczenio, Dorota   +3 more
openaire   +1 more source